Vaxcyte, Inc.: Q1 2026 results
Published 6. 5. 2026, after the market closes. EPS -2,30 $ against an estimate of -1,77.
AI summary
AIThe summary shows how the results turned out, what the company delivered, the pros and cons and why the stock reacted the way it did. We do not have a press release for this quarter yet, so the summary would be based on the numbers alone.